Sandostatin Solution For Injection 1000Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Sandostatin: Solution for injection (1000mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

OCTREOTIDE (ok TREE oh tide) is used to reduce blood levels of growth hormone in patients with a condition called acromegaly. This medicine also reduces flushing and watery diarrhea caused by certain types of cancer.

In-Depth Information

Sandostatin 1000mcg/ml Solution for Injection

NDC: 000780184
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
VIPoma, Carcinoid, Acromegaly

Sometimes used for but not FDA approved for the following conditions:
AIDS-associated Enteropathy, Upper GI Bleeding, Variceal Bleeding, Hepatorenal Syndrome, Thyrotropinoma, Chemotherapy-induced Diarrhea, Ileostomy-associated Diarrhea, Portal Hypertension, Pancreatic Fistula, Dumping Syndrome, Neurogenic Orthostatic Hypotension, Insulinoma, Cluster Headache, Enterocutaneous Fistula, Hyperthyroidism, Esophageal Varices, Short Bowel Syndrome

Storage Information
Protect from light
Store unopened containers in refrigerator (36 to 46 degrees F)
Discard within 14 days after first use
Product is stable for up to 14 days at temperatures between 70 and 86 degrees F if protected from light
Sandostatin 1000mcg/ml Solution for Injection

Reported Side Effects for Sandostatin 1000mcg/ml Solution for Injection

Cranial Nerve Palsies Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Chest Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
<27.3%*
Severity: MILD
Onset: DELAYED
Antibody Formation Incidence:
<25.0%*
Severity: MODERATE
Onset: DELAYED
Fainting Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Blood In The Urine Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Skin Rash Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Paranoia Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
<12.6%*
Severity: MODERATE
Onset: EARLY
Gas Incidence:
<25.7%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
<18.8%*
Severity: MODERATE
Onset: DELAYED
Cholecystitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cholangitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Inflamed Nerve Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Kidney Stones Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Balance Problems Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
<18.2%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
1.0-4.0%*
Severity: MILD
Onset: DELAYED
Visual Impairment Incidence:
1.0-4.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
1.0-13.2%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-4.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Increased Urination Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
1.0-4.0%*
Severity: MODERATE
Onset: EARLY
Tired Incidence:
1.0-11.1%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
1.0-4.0%*
Severity: MILD
Onset: RAPID
Low Blood Sugar Incidence:
1.5-4.0%*
Severity: MODERATE
Onset: EARLY
Enlarged Thyroid Gland Incidence:
2.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Tenesmus Incidence:
4.0-6.0%*
Severity: MILD
Onset: DELAYED
Stool Discoloration Incidence:
4.0-6.0%*
Severity: MILD
Onset: DELAYED
Steatorrhea Incidence:
4.0-6.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
4.4-6.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
5.0-20.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
5.0-61.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
5.0-61.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0-61.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
6.0-30.0%*
Severity: MILD
Onset: EARLY
Gallstones Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
>10.0%*
Severity: MILD
Onset: RAPID
Increased Blood Sugar Incidence:
15.0-27.0%*
Severity: MODERATE
Onset: DELAYED
Slow Heart Beat Incidence:
19.0-25.0%*
Severity: SEVERE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Sandostatin 1000mcg/ml Solution for Injection

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Sandostatin 1000mcg/ml Solution for Injection(Octreotide Acetate)
Marijuana and Octreotide(Octreotide Acetate)
Octreotide can theoretically decrease the elimination of Marijuana, Medical from the body. Side effects from Marijuana, Medical may worsen if you take Octreotide. You may feel drowsy or more tired. Do not drive or operate machinery until you know how these drugs affect you. Contact your health care provider immediately if you notice slurred speech, confusion, increases heart rate, or palpitations while taking Marijuana, Medical.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Sandostatin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5